Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK) HKSE

21.48

+0.22(+1.03%)

Updated at December 05 04:09PM

Currency In HKD

Valuation

Market Cap35.44B
Enterprise Value53.61B
P/E Ratio21.68
PEG Ratio26.67
Price/Sales Ratio1.8
Price/Book Ratio1.48
Enterprise/Revenue2.44
Enterprise/EBITDA20.89

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.08
Operating Margin0.11

Management Effectiveness

Return On Assets0.03
Return On Equity0.07

Income Statement

Revenue41.07B
Revenue/Share14.98
Gross Profit19.7B
EBITDA8.6B
Net Income2.77B
Diluted EPS1.04

Balance Sheet

Total Cash15.64B
Total Cash/Share5.12
Total Debt32.21B
Total Debt/Equity0.77
Current Ratio0.92
Book Value Per Share23.04

Price History

52-Week Change48.95
52-Week High29
52-Week Low12.44
Moving Average 50 Days23.47
Moving Average 200 Days18.98

Statistics

Average Volume6.51M
Shares Outstanding3.44B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.32
Trailing Annual Dividend Yield1.19
Payout Ratio0.29
Last Split FactorN/A
Last Split DateN/A